Shares of Uranium Royalty Corp. (NASDAQ:UROY – Get Free Report) have earned an average recommendation of “Buy” from the five analysts that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $4.1250.
Several research analysts have recently weighed in on the stock. National Bank Financial began coverage on shares of Uranium Royalty in a research note on Wednesday, July 29th. They set an “outperform” rating and a $3.75 price objective on the stock. Zacks Research raised shares of Uranium Royalty from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Weiss Ratings lowered shares of Uranium Royalty from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 17th. Finally, HC Wainwright restated a “buy” rating and set a $4.50 target price on shares of Uranium Royalty in a research note on Thursday, July 16th.
Get Our Latest Report on Uranium Royalty
Uranium Royalty Trading Up 5.5%
Institutional Investors Weigh In On Uranium Royalty
Several hedge funds have recently bought and sold shares of UROY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Uranium Royalty by 7.1% during the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 7,052,298 shares of the company’s stock worth $30,406,000 after acquiring an additional 469,267 shares during the period. CenterBook Partners LP grew its position in shares of Uranium Royalty by 828.7% in the fourth quarter. CenterBook Partners LP now owns 4,447,408 shares of the company’s stock valued at $15,744,000 after purchasing an additional 3,968,521 shares during the last quarter. Alps Advisors Inc. grew its position in shares of Uranium Royalty by 23.7% in the fourth quarter. Alps Advisors Inc. now owns 3,892,680 shares of the company’s stock valued at $13,780,000 after purchasing an additional 745,145 shares during the last quarter. Vident Advisory LLC increased its stake in shares of Uranium Royalty by 4.7% during the third quarter. Vident Advisory LLC now owns 1,549,782 shares of the company’s stock worth $6,674,000 after purchasing an additional 69,631 shares during the period. Finally, Simcoe Capital LLC bought a new position in shares of Uranium Royalty during the fourth quarter worth approximately $4,001,000. 24.19% of the stock is currently owned by institutional investors and hedge funds.
About Uranium Royalty
Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.
The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.
Featured Stories
- Five stocks we like better than Uranium Royalty
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.
